v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Stockholders’ Equity
Common Stock
Capital In Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2024     128,320,295          
Beginning balance at Dec. 31, 2024 $ 1,080,404 $ 1,080,680 $ 1,283 $ 228,889 $ 2,287,151 $ (48,211) $ (1,388,432) $ (276)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 75,526 75,462     75,462     64
Dividends declared (23,082) (23,082)     (23,082)      
Currency translation adjustments 4,135 4,135       4,135    
Derivative financial instruments 484 484       484    
Defined benefit obligations 639 639       639    
Available-for-sale investments (361) (361)       (361)    
Exercises of stock options (in shares)     13,601          
Exercises of stock options 388 388   388        
Shares placed in treasury (43,100) (43,100)         (43,100)  
Stock-based compensation charges (in shares)     310,192          
Stock-based compensation charges 5,047 5,047 $ 3 5,044        
Changes to noncontrolling interests (45)             (45)
Distributions to noncontrolling interests (45)             (45)
Ending balance (in shares) at Mar. 31, 2025     128,644,088          
Ending balance at Mar. 31, 2025 1,100,035 1,100,292 $ 1,286 234,321 2,339,531 (43,314) (1,431,532) (257)
Beginning balance (in shares) at Dec. 31, 2024     128,320,295          
Beginning balance at Dec. 31, 2024 1,080,404 1,080,680 $ 1,283 228,889 2,287,151 (48,211) (1,388,432) (276)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 153,988              
Currency translation adjustments 23,838              
Ending balance (in shares) at Jun. 30, 2025     128,680,180          
Ending balance at Jun. 30, 2025 1,183,906 1,184,164 $ 1,286 243,068 2,394,737 (23,385) (1,431,542) (258)
Beginning balance (in shares) at Mar. 31, 2025     128,644,088          
Beginning balance at Mar. 31, 2025 1,100,035 1,100,292 $ 1,286 234,321 2,339,531 (43,314) (1,431,532) (257)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 78,462 78,388     78,388     74
Dividends declared (23,182) (23,182)     (23,182)      
Currency translation adjustments 19,703 19,703       19,703    
Derivative financial instruments (431) (431)       (431)    
Defined benefit obligations 657 657       657    
Exercises of stock options (in shares)     746          
Exercises of stock options 59 59   59        
Shares placed in treasury (10) (10)         (10)  
Stock-based compensation charges (in shares)     35,346          
Stock-based compensation charges 8,688 8,688   8,688        
Changes to noncontrolling interests (75)             (75)
Distributions to noncontrolling interests (75)             (75)
Ending balance (in shares) at Jun. 30, 2025     128,680,180          
Ending balance at Jun. 30, 2025 $ 1,183,906 1,184,164 $ 1,286 243,068 2,394,737 (23,385) (1,431,542) (258)
Beginning balance (in shares) at Dec. 31, 2025 128,720,819   128,720,819          
Beginning balance at Dec. 31, 2025 $ 1,233,012 1,232,487 $ 1,288 159,884 2,523,631 (19,373) (1,432,943) 525
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 91,189 91,068     91,068     121
Dividends declared (24,875) (24,875)     (24,875)      
Currency translation adjustments (12,986) (12,986)       (12,986)    
Derivative financial instruments 153 153       153    
Defined benefit obligations 795 795       795    
Exercises of stock options (in shares)     37,687          
Exercises of stock options 2,999 2,999   2,999        
Shares placed in treasury (19,387) (19,387)         (19,387)  
Stock-based compensation charges (in shares)     239,218          
Stock-based compensation charges 10,169 10,169 $ 1 10,168        
Changes to noncontrolling interests (837)             (837)
Distributions to noncontrolling interests (837)             (837)
Ending balance (in shares) at Mar. 31, 2026     128,997,724          
Ending balance at Mar. 31, 2026 $ 1,280,232 1,280,423 $ 1,289 173,051 2,589,824 (31,411) (1,452,330) (191)
Beginning balance (in shares) at Dec. 31, 2025 128,720,819   128,720,819          
Beginning balance at Dec. 31, 2025 $ 1,233,012 1,232,487 $ 1,288 159,884 2,523,631 (19,373) (1,432,943) 525
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 180,289              
Currency translation adjustments $ (34,056)              
Ending balance (in shares) at Jun. 30, 2026 129,006,562   129,006,562          
Ending balance at Jun. 30, 2026 $ 1,334,149 1,334,450 $ 1,289 183,530 2,653,709 (51,334) (1,452,744) (301)
Beginning balance (in shares) at Mar. 31, 2026     128,997,724          
Beginning balance at Mar. 31, 2026 1,280,232 1,280,423 $ 1,289 173,051 2,589,824 (31,411) (1,452,330) (191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 89,098 89,014     89,014     84
Dividends declared (25,129) (25,129)     (25,129)      
Currency translation adjustments (21,070) (21,070)       (21,070)    
Derivative financial instruments 351 351       351    
Defined benefit obligations 796 796       796    
Available-for-sale investments 0              
Exercises of stock options (in shares)     6,742          
Exercises of stock options 529 529   529        
Shares placed in treasury (414) (414)         (414)  
Stock-based compensation charges (in shares)     2,096          
Stock-based compensation charges 9,950 9,950   9,950        
Changes to noncontrolling interests (194)             (194)
Distributions to noncontrolling interests $ (194)             (194)
Ending balance (in shares) at Jun. 30, 2026 129,006,562   129,006,562          
Ending balance at Jun. 30, 2026 $ 1,334,149 $ 1,334,450 $ 1,289 $ 183,530 $ 2,653,709 $ (51,334) $ (1,452,744) $ (301)